Bristol-Myers Squibb is buying Celgene for $ 74 billion

    Bristol-Myers Squibb is buying Celgene for $ 74 billion

Bristol-Myers Squibb and Celgene can make the biggest deal of the coming year. BMS wants to buy Celgene for $ 74 billion. Official releases say that one share will cost

0 comment Read Full Article